tiprankstipranks
Bausch Health Companies (BHC)
:BHC
US Market

Bausch Health Companies (BHC) Earnings Dates, Call Summary & Reports

Compare
2,425 Followers

Earnings Data

Report Date
May 01, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0.85
Last Year’s EPS
0.61
Same Quarter Last Year
Based on 4 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 19, 2025
|
% Change Since: 10.29%
|
Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
Bausch Health demonstrated strong operational and financial performance in 2024, with consecutive quarters of revenue and EBITDA growth, significant cash flow generation, and strategic advancements in key segments. However, challenges such as foreign exchange impacts, legal proceedings, and declines in certain segments present areas of concern.
Company Guidance
During the Bausch Health Fourth Quarter 2024 Earnings Call, the company highlighted its robust performance and provided financial guidance for 2025. Bausch Health, excluding Bausch + Lomb, achieved a 4% increase in reported revenue and a 7% rise in organic revenue for the fourth quarter, while full-year revenues rose by 5% reported and 6% organic compared to 2023. Adjusted EBITDA for the fourth quarter increased by 7%, and the full year saw an 8% rise, with adjusted operating cash flow reaching approximately $1.3 billion. The 2025 guidance projects revenues between $4.950 billion and $5.100 billion, a 4% year-over-year increase, and adjusted EBITDA between $2.625 billion and $2.725 billion, a 5% increase. Adjusted operating cash flow is expected to be between $975 million and $1.025 billion. The call emphasized strategic priorities focusing on people, growth, innovation, efficiency, and unlocking value, as well as efforts to optimize the capital structure and explore monetization of Bausch + Lomb assets.
Consistent Revenue and EBITDA Growth
Bausch Health marked its seventh consecutive quarter of revenue and adjusted EBITDA growth, with a 4% revenue increase on a reported basis and 7% on an organic basis for Q4 2024. Full-year revenue increased by 5% on a reported basis and 6% on an organic basis.
Strong Cash Flow Generation
The company generated approximately $1.3 billion in adjusted operating cash flow for the full year, which exceeded guidance, driven by operational performance, low cash taxes, and favorable timing of outflows.
Solta Medical Segment Performance
Solta revenue increased by 34% in Q4, primarily driven by volume and strong performance in South Korea and China. The segment is well-positioned for sustained growth.
Xifaxan Revenue Growth
Xifaxan delivered a 16% revenue growth in Q4, with solid volume growth across all channels, marking the fourth consecutive quarter of growth.
International Business Growth
Canada achieved double-digit growth in promoted brands, and EMEA business achieved its eighth consecutive quarter of organic growth.
---

Bausch Health Companies (BHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 01, 20252025 (Q1)
0.87 / -
0.608
Feb 19, 20252024 (Q4)
1.14 / 1.14
0.92423.65% (+0.22)
Oct 30, 20242024 (Q3)
1.00 / 1.12
1.0437.57% (+0.08)
Jul 31, 20242024 (Q2)
0.85 / 1.04
0.77134.83% (+0.27)
May 02, 20242024 (Q1)
0.66 / 0.61
0.52715.53% (+0.08)
Feb 22, 20242023 (Q4)
0.97 / 0.92
1-7.61% (-0.08)
Nov 02, 20232023 (Q3)
0.89 / 1.04
0.76636.28% (+0.28)
Aug 03, 20232023 (Q2)
0.66 / 0.77
0.50353.22% (+0.27)
May 04, 20232023 (Q1)
0.62 / 0.53
0.664-20.70% (-0.14)
Feb 23, 20232022 (Q4)
0.90 / 1.00
1.141-12.35% (-0.14)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

BHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 19, 2025$6.51$7.18+10.29%
Oct 30, 2024$8.17$9.20+12.61%
Jul 31, 2024$5.96$6.03+1.17%
May 02, 2024$8.75$8.09-7.54%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Bausch Health Companies (BHC) report earnings?
Bausch Health Companies (BHC) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
    What is Bausch Health Companies (BHC) earnings time?
    Bausch Health Companies (BHC) earnings time is at May 01, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BHC EPS forecast?
          BHC EPS forecast for the fiscal quarter 2025 (Q1) is 0.85.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis